Individual and Specified Hormones - Medical Devices Pipeline Assessment, 2018
- GDME0657EPD
- Pages: 106
- July 2018
- Total Views:1134
- Region : Global
- GlobalData
- Market Research Report

Details
Individual and Specified Hormones-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Individual and Specified Hormones-Medical Devices Pipeline Assessment, 2018" provides an overview of Individual and Specified Hormones currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Individual and Specified Hormones pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Individual and Specified Hormones under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Individual and Specified Hormones and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Individual and Specified Hormones under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Table Of Content
Scope
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Individual and Specified Hormones Overview 7
3 Products under Development 8
3.1 Individual and Specified Hormones-Pipeline Products by Stage of Development 8
3.2 Individual and Specified Hormones-Pipeline Products by Segment 9
3.3 Individual and Specified Hormones-Pipeline Products by Territory 10
3.4 Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
3.5 Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
4 Individual and Specified Hormones-Pipeline Products under Development by Companies 13
4.1 Individual and Specified Hormones Companies-Pipeline Products by Stage of Development 13
4.2 Individual and Specified Hormones-Pipeline Products by Stage of Development 14
5 Individual and Specified Hormones Companies and Product Overview 16
5.1 Alere Inc Company Overview 16
5.2 AMS Diagnostics LLC Company Overview 17
5.3 Beckman Coulter Inc Company Overview 19
5.4 Carolina Liquid Chemistries Corp Company Overview 20
5.5 Ceres Nanosciences Inc Company Overview 22
5.6 Columbia University Company Overview 23
5.7 DiaSorin SpA Company Overview 24
5.8 DIAsource ImmunoAssays SA Company Overview 27
5.9 Fujirebio Diagnostics Inc Company Overview 29
5.10 Immunodiagnostic Systems Holdings plc Company Overview 30
5.11 Mindray Medical International Ltd Company Overview 33
5.12 Novartis AG Company Overview 39
5.13 OJ-Bio Ltd Company Overview 40
5.14 Roche Diagnostics International Ltd Company Overview 41
5.15 Sendera Discovery Company Overview 51
5.16 Siemens Healthcare GmbH Company Overview 52
5.17 Thermo Fisher Scientific Inc Company Overview 59
5.18 Tosoh Bioscience Inc Company Overview 60
6 Individual and Specified Hormones- Recent Developments 61
6.1 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 61
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 65
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 66
6.4 May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 67
6.5 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 69
6.6 May 07, 2018: Luminex Announces First Quarter 2018 Financial Results 70
6.7 May 03, 2018: Siemens Healthineers fully on track to meet the targets 70
6.8 Apr 23, 2018: Science Start-Ups Gain Strong Momentum at the Prince William Science Accelerator 71
6.9 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 72
6.10 Mar 26, 2018: New Study Highlights the Use of MR-proADM in Assessing Disease Severity and Treatment Response in Patients with Sepsis and Septic Shock 75
6.11 Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018 75
6.12 Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results 76
6.13 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 76
6.14 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 77
6.15 Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers 79
6.16 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 80
6.17 Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 80
6.18 Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 87
6.19 Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 88
6.20 Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 89
6.21 Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 90
6.22 Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 91
6.23 Sep 22, 2017: Abbott and the Abbott Fund Provide USD2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 94
6.24 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With USD1 Million to Help Families Affected by Hurricane Irma 95
6.25 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 95
6.26 Aug 29, 2017: Abbott and the Abbott Fund Donate USD1 Million to Support Hurricane Harvey Relief Efforts 96
6.27 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 96
6.28 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 97
6.29 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 100
7 Appendix 103
7.1 Methodology 103
7.2 About GlobalData 106
7.3 Contact Us 106
7.4 Disclaimer 106
List Of Figure
1.2 List of Figures
Figure 1: Individual and Specified Hormones-Pipeline Products by Stage of Development 8
Figure 2: Individual and Specified Hormones-Pipeline Products by Segment 9
Figure 3: Individual and Specified Hormones-Pipeline Products by Territory 10
Figure 4: Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
Figure 5: Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
List Of Table
1.1 List of Tables
Table 1: Individual and Specified Hormones-Pipeline Products by Stage of Development 8
Table 2: Individual and Specified Hormones-Pipeline Products by Segment 9
Table 3: Individual and Specified Hormones-Pipeline Products by Territory 10
Table 4: Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
Table 5: Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
Table 6: Individual and Specified Hormones Companies-Pipeline Products by Stage of Development 13
Table 7: Individual and Specified Hormones-Pipeline Products by Stage of Development 14
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 9: Vitamin D Assay-Product Status 16
Table 10: Vitamin D Assay-Product Description 16
Table 11: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 17
Table 12: LIASYS 330-Vitamin D Assay-Product Status 17
Table 13: LIASYS 330-Vitamin D Assay-Product Description 17
Table 14: Liasys 450-Vitamin D Assay-Product Status 17
Table 15: Liasys 450-Vitamin D Assay-Product Description 18
Table 16: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: UniCel DxI 860i Synchron Access Clinical System-Vitamin D Assay-Product Status 19
Table 18: UniCel DxI 860i Synchron Access Clinical System-Vitamin D Assay-Product Description 19
Table 19: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: CLC 480 Analyzer-Vitamin D Assay-Product Status 20
Table 21: CLC 480 Analyzer-Vitamin D Assay-Product Description 20
Table 22: CLC 720i Analyzer-Vitamin D Assay-Product Status 21
Table 23: CLC 720i Analyzer-Vitamin D Assay-Product Description 21
Table 24: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 25: Nanotrap Human Growth Hormone Test-Product Status 22
Table 26: Nanotrap Human Growth Hormone Test-Product Description 22
Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: Diagnostic Test-Menopause-Product Status 23
Table 29: Diagnostic Test-Menopause-Product Description 23
Table 30: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 24
Table 31: LIAISON-High Sclerostin Assay-Product Status 24
Table 32: LIAISON-High Sclerostin Assay-Product Description 25
Table 33: LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Status 25
Table 34: LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Description 25
Table 35: LIAISON XL-Sclerostin Assay-Product Status 26
Table 36: LIAISON XL-Sclerostin Assay-Product Description 26
Table 37: DIAsource ImmunoAssays SA Pipeline Products & Ongoing Clinical Trials Overview 27
Table 38: 25-OH Vitamin D Total ELISA Test-Product Status 27
Table 39: 25-OH Vitamin D Total ELISA Test-Product Description 28
Table 40: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 41: Lumipulse G1200-Whole PTH-Product Status 29
Table 42: Lumipulse G1200-Whole PTH-Product Description 29
Table 43: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 44: IDS-iSYS Cortisol Assay-Product Status 30
Table 45: IDS-iSYS Cortisol Assay-Product Description 30
Table 46: IDS-iSYS Intact PINP Assay-Product Status 31
Table 47: IDS-iSYS Intact PINP Assay-Product Description 31
Table 48: IDS-iSYS MGP Assay-Product Status 31
Table 49: IDS-iSYS MGP Assay-Product Description 32
Table 50: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 51: CL-1000i-Calcitonin Test-Product Status 33
Table 52: CL-1000i-Calcitonin Test-Product Description 33
Table 53: CL-1000i-Intact PTH Test-Product Status 34
Table 54: CL-1000i-Intact PTH Test-Product Description 34
Table 55: CL-1000i-Vitamin D Total Test-Product Status 34
Table 56: CL-1000i-Vitamin D Total Test-Product Description 35
Table 57: CL-2000i-ACTH Test-Product Status 35
Table 58: CL-2000i-ACTH Test-Product Description 35
Table 59: CL-2000i-Calcitonin Test-Product Status 36
Table 60: CL-2000i-Calcitonin Test-Product Description 36
Table 61: CL-2000i-Cortisol Test-Product Status 36
Table 62: CL-2000i-Cortisol Test-Product Description 37
Table 63: CL-2000i-PTH Test-Product Status 37
Table 64: CL-2000i-PTH Test-Product Description 37
Table 65: CL-2000i-Vitamin D Total Test-Product Status 38
Table 66: CL-2000i-Vitamin D Total Test-Product Description 38
Table 67: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 39
Table 68: Rapid Diagnostic Test-Vitamin D-Product Status 39
Table 69: Rapid Diagnostic Test-Vitamin D-Product Description 39
Table 70: OJ-Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
Table 71: Parathyroid Hormone Assay-Product Status 40
Table 72: Parathyroid Hormone Assay-Product Description 40
Table 73: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 74: Cobas 4000 Analyzer Series With e 411 Module-IGF-1 Assay-Product Status 42
Table 75: Cobas 4000 Analyzer Series With e 411 Module-IGF-1 Assay-Product Description 42
Table 76: Cobas 6000 Analyzer Series With c 501 Module-IGF BP3 Assay-Product Status 42
Table 77: Cobas 6000 Analyzer Series With c 501 Module-IGF BP3 Assay-Product Description 43
Table 78: Cobas 6000 Analyzer Series With c 501 Module-IGF-1 Assay-Product Status 43
Table 79: Cobas 6000 Analyzer Series With c 501 Module-IGF-1 Assay-Product Description 43
Table 80: Cobas 6000 Analyzer Series With e 601 Module-IGF BP3 Assay-Product Status 43
Table 81: Cobas 6000 Analyzer Series With e 601 Module-IGF BP3 Assay-Product Description 44
Table 82: Cobas 6000 Analyzer Series With e 601 Module-IGF-1 Assay-Product Status 44
Table 83: Cobas 6000 Analyzer Series With e 601 Module-IGF-1 Assay-Product Description 44
Table 84: Cobas 8000 Analyzer Series With c 502 Module-IGF BP3 Assay-Product Status 45
Table 85: Cobas 8000 Analyzer Series With c 502 Module-IGF BP3 Assay-Product Description 45
Table 86: Cobas 8000 Analyzer Series With c 502 Module-IGF-1 Assay-Product Status 45
Table 87: Cobas 8000 Analyzer Series With c 502 Module-IGF-1 Assay-Product Description 46
Table 88: Cobas 8000 Analyzer Series With c 701 Module-IGF BP3 Assay-Product Status 46
Table 89: Cobas 8000 Analyzer Series With c 701 Module-IGF BP3 Assay-Product Description 46
Table 90: Cobas 8000 Analyzer Series With c 701 Module-IGF-1-Product Status 47
Table 91: Cobas 8000 Analyzer Series With c 701 Module-IGF-1-Product Description 47
Table 92: Cobas 8000 Analyzer Series With c 702 Module-IGF-1 Assay-Product Status 47
Table 93: Cobas 8000 Analyzer Series With c 702 Module-IGF-1 Assay-Product Description 48
Table 94: Cobas 8000 Analyzer Series With e 602 Module-IGF BP3 Assay-Product Status 48
Table 95: Cobas 8000 Analyzer Series With e 602 Module-IGF BP3 Assay-Product Description 48
Table 96: Cobas 8000 Analyzer Series With e 602 Module-IGF-1 Assay-Product Status 49
Table 97: Cobas 8000 Analyzer Series With e 602 Module-IGF-1 Assay-Product Description 49
Table 98: Cobas 8000 Analyzer Series With e 801 Module-IGF BP3 Assay-Product Status 49
Table 99: Cobas 8000 Analyzer Series With e 801 Module-IGF BP3 Assay-Product Description 50
Table 100: Cobas 8000 Analyzer Series With e 801 Module-IGF-1 Assay-Product Status 50
Table 101: Cobas 8000 Analyzer Series With e 801 Module-IGF-1 Assay-Product Description 50
Table 102: Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 51
Table 103: In-Vitro Diagnostic Kit-Androgen Replacement Therapy-Product Status 51
Table 104: In-Vitro Diagnostic Kit-Androgen Replacement Therapy-Product Description 51
Table 105: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 52
Table 106: ADVIA Centaur CP Immunoassay System-Vitamin D Assay-Product Status 52
Table 107: ADVIA Centaur CP Immunoassay System-Vitamin D Assay-Product Description 53
Table 108: Dimension EXL 200 Integrated Chemistry System-LOCI IPTH-Product Status 53
Table 109: Dimension EXL 200 Integrated Chemistry System-LOCI IPTH-Product Description 53
Table 110: Dimension EXL 200 Integrated Chemistry System-Vitamin D Assay-Product Status 54
Licence Rights
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
Section Purchase
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products and Companies
Products
Alere Inc, Vitamin D Assay; AMS Diagnostics LLC, LIASYS 330 - Vitamin D Assay; AMS Diagnostics LLC, Liasys 450 - Vitamin D Assay; Beckman Coulter Inc, UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay; Carolina Liquid Chemistries Corp, CLC 480 Analyzer - Vitamin D Assay; Carolina Liquid Chemistries Corp, CLC 720i Analyzer - Vitamin D Assay; Ceres Nanosciences Inc, Nanotrap Human Growth Hormone Test; Columbia University, Diagnostic Test - Menopause; DiaSorin SpA, LIAISON - High Sclerostin Assay; DiaSorin SpA, LIAISON - Hyperphosphate Low Bone Turnover Assay; DiaSorin SpA, LIAISON XL - Sclerostin Assay; DIAsource ImmunoAssays SA, 25-OH Vitamin D Total ELISA Test; Fujirebio Diagnostics Inc, Lumipulse G1200 - Whole PTH; Immunodiagnostic Systems Holdings plc, IDS-iSYS Cortisol Assay; Immunodiagnostic Systems Holdings plc, IDS-iSYS Intact PINP Assay; Immunodiagnostic Systems Holdings plc, IDS-iSYS MGP Assay; Mindray Medical International Ltd, CL-1000i - Calcitonin Test; Mindray Medical International Ltd, CL-1000i - Intact PTH Test; Mindray Medical International Ltd, CL-1000i - Vitamin D Total Test; Mindray Medical International Ltd, CL-2000i - ACTH Test; Mindray Medical International Ltd, CL-2000i - Calcitonin Test; Mindray Medical International Ltd, CL-2000i - Cortisol Test; Mindray Medical International Ltd, CL-2000i - PTH Test; Mindray Medical International Ltd, CL-2000i - Vitamin D Total Test; Novartis AG, Rapid Diagnostic Test - Vitamin D; OJ-Bio Ltd, Parathyroid Hormone Assay; Roche Diagnostics International Ltd, Cobas 4000 Analyzer Series With e 411 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With e 601 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With e 601 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 701 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 701 Module - IGF-1; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 702 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 602 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 602 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 801 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 801 Module - IGF-1 Assay; Sendera Discovery, In-Vitro Diagnostic Kit - Androgen Replacement Therapy; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL 200 Integrated Chemistry System - LOCI IPTH; Siemens Healthcare GmbH, Dimension EXL 200 Integrated Chemistry System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI Cortisol Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI IPTH Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL With LM Integrated Chemistry System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension Vista 1000T Intelligent Lab System - Cortisol Assay; Siemens Healthcare GmbH, Dimension Vista 1500 Intelligent Lab System - Loci Vitamin D Assay; Siemens Healthcare GmbH, Dimension Vista 3000T Intelligent Lab System - Cortisol Assay; Siemens Healthcare GmbH, Dimension Vista 500 Intelligent Lab System - Cortisol Assay; Thermo Fisher Scientific Inc, Cascadion SM Clinical Analyzer - 25OH Vitamin D Assay; Tosoh Bioscience Inc, AIA-360 - Vitamin D Test
Companies
Alere Inc
AMS Diagnostics LLC
Beckman Coulter Inc
Carolina Liquid Chemistries Corp
Ceres Nanosciences Inc
Columbia University
DiaSorin SpA
DIAsource ImmunoAssays SA
Fujirebio Diagnostics Inc
Immunodiagnostic Systems Holdings plc
Mindray Medical International Ltd
Novartis AG
OJ-Bio Ltd
Roche Diagnostics International Ltd
Sendera Discovery
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
Tosoh Bioscience Inc
Company Profile
Company Profile Title
Individual and Specified Hormones-Medical Devices Pipeline Assessment, 2018
Summary
GlobalData's Medical Devices sector report, Individual and Specified Hormones-Medical Devices Pipeline Assessment, 2018" provides an overview of Individual and Specified Hormones currently in pipeline stage.
The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Individual and Specified Hormones pipeline products.
This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.
*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
- Extensive coverage of the Individual and Specified Hormones under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Individual and Specified Hormones and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry.
Reasons to buy
The report enables you to-
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Individual and Specified Hormones under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date.
Scope
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 6
2 Introduction 7
2.1 Individual and Specified Hormones Overview 7
3 Products under Development 8
3.1 Individual and Specified Hormones-Pipeline Products by Stage of Development 8
3.2 Individual and Specified Hormones-Pipeline Products by Segment 9
3.3 Individual and Specified Hormones-Pipeline Products by Territory 10
3.4 Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
3.5 Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
4 Individual and Specified Hormones-Pipeline Products under Development by Companies 13
4.1 Individual and Specified Hormones Companies-Pipeline Products by Stage of Development 13
4.2 Individual and Specified Hormones-Pipeline Products by Stage of Development 14
5 Individual and Specified Hormones Companies and Product Overview 16
5.1 Alere Inc Company Overview 16
5.2 AMS Diagnostics LLC Company Overview 17
5.3 Beckman Coulter Inc Company Overview 19
5.4 Carolina Liquid Chemistries Corp Company Overview 20
5.5 Ceres Nanosciences Inc Company Overview 22
5.6 Columbia University Company Overview 23
5.7 DiaSorin SpA Company Overview 24
5.8 DIAsource ImmunoAssays SA Company Overview 27
5.9 Fujirebio Diagnostics Inc Company Overview 29
5.10 Immunodiagnostic Systems Holdings plc Company Overview 30
5.11 Mindray Medical International Ltd Company Overview 33
5.12 Novartis AG Company Overview 39
5.13 OJ-Bio Ltd Company Overview 40
5.14 Roche Diagnostics International Ltd Company Overview 41
5.15 Sendera Discovery Company Overview 51
5.16 Siemens Healthcare GmbH Company Overview 52
5.17 Thermo Fisher Scientific Inc Company Overview 59
5.18 Tosoh Bioscience Inc Company Overview 60
6 Individual and Specified Hormones- Recent Developments 61
6.1 Jun 20, 2018: Immunodiagnostic Systems: Final Results for year ended 31 March 2018 61
6.2 Jun 12, 2018: Change at the top of the Segment Advanced Therapies at Siemens Healthineers 65
6.3 Jun 01, 2018: ISBT Satellite Symposium Co-hosted by Ortho Clinical Diagnostics and Quotient Discusses Responding to the Challenges of Resource Constraints in Transfusion Diagnostics 66
6.4 May 08, 2018: The Diasorin Group Reports Growth in Revenues and Profitability in the First Quarter 2018 67
6.5 May 08, 2018: Ortho Clinical Diagnostics Holds Summit to Help Asia-Pacific Lab Leaders Envision the Lab of the Future 69
6.6 May 07, 2018: Luminex Announces First Quarter 2018 Financial Results 70
6.7 May 03, 2018: Siemens Healthineers fully on track to meet the targets 70
6.8 Apr 23, 2018: Science Start-Ups Gain Strong Momentum at the Prince William Science Accelerator 71
6.9 Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 72
6.10 Mar 26, 2018: New Study Highlights the Use of MR-proADM in Assessing Disease Severity and Treatment Response in Patients with Sepsis and Septic Shock 75
6.11 Mar 21, 2018: Immunodiagnostic Systems Holdings: Directorate Change 2018 75
6.12 Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results 76
6.13 Jan 30, 2018: Siemens Healthineers Names Deepak Nath Head of Laboratory Diagnostics 76
6.14 Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 77
6.15 Jan 22, 2018: FDA Grants Diazyme 510(k) Clearance to Market Its New EZ Vitamin D Assay for Clinical Chemistry Analyzers 79
6.16 Nov 29, 2017: Siemens plans to list Siemens Healthineers on Frankfurt Stock Exchange 80
6.17 Nov 24, 2017: Immunodiagnostic Systems Holdings: Unaudited Interim Results for the six month period ended 30 September 2017 80
6.18 Nov 09, 2017: Growth In Revenues And Net Profit In Q3 2017. Strong Free Cash Flow Generation. 2017 Guidance Confirmed 87
6.19 Oct 31, 2017: Immunodiagnostic Systems Holdings: Directorate Change 88
6.20 Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 89
6.21 Oct 20, 2017: Immunodiagnostic Systems Holdings: H1 Trading Update 2017 90
6.22 Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 91
6.23 Sep 22, 2017: Abbott and the Abbott Fund Provide USD2 Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 94
6.24 Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With USD1 Million to Help Families Affected by Hurricane Irma 95
6.25 Sep 07, 2017: Abbott Named Industry Leader for Responsible and Sustainable Business for Five Consecutive Years on the Dow Jones Sustainability Index 95
6.26 Aug 29, 2017: Abbott and the Abbott Fund Donate USD1 Million to Support Hurricane Harvey Relief Efforts 96
6.27 Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 96
6.28 Aug 03, 2017: Diasorin Group Reports Strong Growth in Revenues and Profitability in Q2 2017 97
6.29 Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 100
7 Appendix 103
7.1 Methodology 103
7.2 About GlobalData 106
7.3 Contact Us 106
7.4 Disclaimer 106
List Of Figure
1.2 List of Figures
Figure 1: Individual and Specified Hormones-Pipeline Products by Stage of Development 8
Figure 2: Individual and Specified Hormones-Pipeline Products by Segment 9
Figure 3: Individual and Specified Hormones-Pipeline Products by Territory 10
Figure 4: Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
Figure 5: Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
List Of Table
1.1 List of Tables
Table 1: Individual and Specified Hormones-Pipeline Products by Stage of Development 8
Table 2: Individual and Specified Hormones-Pipeline Products by Segment 9
Table 3: Individual and Specified Hormones-Pipeline Products by Territory 10
Table 4: Individual and Specified Hormones-Pipeline Products by Regulatory Path 11
Table 5: Individual and Specified Hormones-Pipeline Products by Estimated Approval Date 12
Table 6: Individual and Specified Hormones Companies-Pipeline Products by Stage of Development 13
Table 7: Individual and Specified Hormones-Pipeline Products by Stage of Development 14
Table 8: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview 16
Table 9: Vitamin D Assay-Product Status 16
Table 10: Vitamin D Assay-Product Description 16
Table 11: AMS Diagnostics LLC Pipeline Products & Ongoing Clinical Trials Overview 17
Table 12: LIASYS 330-Vitamin D Assay-Product Status 17
Table 13: LIASYS 330-Vitamin D Assay-Product Description 17
Table 14: Liasys 450-Vitamin D Assay-Product Status 17
Table 15: Liasys 450-Vitamin D Assay-Product Description 18
Table 16: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview 19
Table 17: UniCel DxI 860i Synchron Access Clinical System-Vitamin D Assay-Product Status 19
Table 18: UniCel DxI 860i Synchron Access Clinical System-Vitamin D Assay-Product Description 19
Table 19: Carolina Liquid Chemistries Corp Pipeline Products & Ongoing Clinical Trials Overview 20
Table 20: CLC 480 Analyzer-Vitamin D Assay-Product Status 20
Table 21: CLC 480 Analyzer-Vitamin D Assay-Product Description 20
Table 22: CLC 720i Analyzer-Vitamin D Assay-Product Status 21
Table 23: CLC 720i Analyzer-Vitamin D Assay-Product Description 21
Table 24: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 22
Table 25: Nanotrap Human Growth Hormone Test-Product Status 22
Table 26: Nanotrap Human Growth Hormone Test-Product Description 22
Table 27: Columbia University Pipeline Products & Ongoing Clinical Trials Overview 23
Table 28: Diagnostic Test-Menopause-Product Status 23
Table 29: Diagnostic Test-Menopause-Product Description 23
Table 30: DiaSorin SpA Pipeline Products & Ongoing Clinical Trials Overview 24
Table 31: LIAISON-High Sclerostin Assay-Product Status 24
Table 32: LIAISON-High Sclerostin Assay-Product Description 25
Table 33: LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Status 25
Table 34: LIAISON-Hyperphosphate Low Bone Turnover Assay-Product Description 25
Table 35: LIAISON XL-Sclerostin Assay-Product Status 26
Table 36: LIAISON XL-Sclerostin Assay-Product Description 26
Table 37: DIAsource ImmunoAssays SA Pipeline Products & Ongoing Clinical Trials Overview 27
Table 38: 25-OH Vitamin D Total ELISA Test-Product Status 27
Table 39: 25-OH Vitamin D Total ELISA Test-Product Description 28
Table 40: Fujirebio Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview 29
Table 41: Lumipulse G1200-Whole PTH-Product Status 29
Table 42: Lumipulse G1200-Whole PTH-Product Description 29
Table 43: Immunodiagnostic Systems Holdings plc Pipeline Products & Ongoing Clinical Trials Overview 30
Table 44: IDS-iSYS Cortisol Assay-Product Status 30
Table 45: IDS-iSYS Cortisol Assay-Product Description 30
Table 46: IDS-iSYS Intact PINP Assay-Product Status 31
Table 47: IDS-iSYS Intact PINP Assay-Product Description 31
Table 48: IDS-iSYS MGP Assay-Product Status 31
Table 49: IDS-iSYS MGP Assay-Product Description 32
Table 50: Mindray Medical International Ltd Pipeline Products & Ongoing Clinical Trials Overview 33
Table 51: CL-1000i-Calcitonin Test-Product Status 33
Table 52: CL-1000i-Calcitonin Test-Product Description 33
Table 53: CL-1000i-Intact PTH Test-Product Status 34
Table 54: CL-1000i-Intact PTH Test-Product Description 34
Table 55: CL-1000i-Vitamin D Total Test-Product Status 34
Table 56: CL-1000i-Vitamin D Total Test-Product Description 35
Table 57: CL-2000i-ACTH Test-Product Status 35
Table 58: CL-2000i-ACTH Test-Product Description 35
Table 59: CL-2000i-Calcitonin Test-Product Status 36
Table 60: CL-2000i-Calcitonin Test-Product Description 36
Table 61: CL-2000i-Cortisol Test-Product Status 36
Table 62: CL-2000i-Cortisol Test-Product Description 37
Table 63: CL-2000i-PTH Test-Product Status 37
Table 64: CL-2000i-PTH Test-Product Description 37
Table 65: CL-2000i-Vitamin D Total Test-Product Status 38
Table 66: CL-2000i-Vitamin D Total Test-Product Description 38
Table 67: Novartis AG Pipeline Products & Ongoing Clinical Trials Overview 39
Table 68: Rapid Diagnostic Test-Vitamin D-Product Status 39
Table 69: Rapid Diagnostic Test-Vitamin D-Product Description 39
Table 70: OJ-Bio Ltd Pipeline Products & Ongoing Clinical Trials Overview 40
Table 71: Parathyroid Hormone Assay-Product Status 40
Table 72: Parathyroid Hormone Assay-Product Description 40
Table 73: Roche Diagnostics International Ltd Pipeline Products & Ongoing Clinical Trials Overview 41
Table 74: Cobas 4000 Analyzer Series With e 411 Module-IGF-1 Assay-Product Status 42
Table 75: Cobas 4000 Analyzer Series With e 411 Module-IGF-1 Assay-Product Description 42
Table 76: Cobas 6000 Analyzer Series With c 501 Module-IGF BP3 Assay-Product Status 42
Table 77: Cobas 6000 Analyzer Series With c 501 Module-IGF BP3 Assay-Product Description 43
Table 78: Cobas 6000 Analyzer Series With c 501 Module-IGF-1 Assay-Product Status 43
Table 79: Cobas 6000 Analyzer Series With c 501 Module-IGF-1 Assay-Product Description 43
Table 80: Cobas 6000 Analyzer Series With e 601 Module-IGF BP3 Assay-Product Status 43
Table 81: Cobas 6000 Analyzer Series With e 601 Module-IGF BP3 Assay-Product Description 44
Table 82: Cobas 6000 Analyzer Series With e 601 Module-IGF-1 Assay-Product Status 44
Table 83: Cobas 6000 Analyzer Series With e 601 Module-IGF-1 Assay-Product Description 44
Table 84: Cobas 8000 Analyzer Series With c 502 Module-IGF BP3 Assay-Product Status 45
Table 85: Cobas 8000 Analyzer Series With c 502 Module-IGF BP3 Assay-Product Description 45
Table 86: Cobas 8000 Analyzer Series With c 502 Module-IGF-1 Assay-Product Status 45
Table 87: Cobas 8000 Analyzer Series With c 502 Module-IGF-1 Assay-Product Description 46
Table 88: Cobas 8000 Analyzer Series With c 701 Module-IGF BP3 Assay-Product Status 46
Table 89: Cobas 8000 Analyzer Series With c 701 Module-IGF BP3 Assay-Product Description 46
Table 90: Cobas 8000 Analyzer Series With c 701 Module-IGF-1-Product Status 47
Table 91: Cobas 8000 Analyzer Series With c 701 Module-IGF-1-Product Description 47
Table 92: Cobas 8000 Analyzer Series With c 702 Module-IGF-1 Assay-Product Status 47
Table 93: Cobas 8000 Analyzer Series With c 702 Module-IGF-1 Assay-Product Description 48
Table 94: Cobas 8000 Analyzer Series With e 602 Module-IGF BP3 Assay-Product Status 48
Table 95: Cobas 8000 Analyzer Series With e 602 Module-IGF BP3 Assay-Product Description 48
Table 96: Cobas 8000 Analyzer Series With e 602 Module-IGF-1 Assay-Product Status 49
Table 97: Cobas 8000 Analyzer Series With e 602 Module-IGF-1 Assay-Product Description 49
Table 98: Cobas 8000 Analyzer Series With e 801 Module-IGF BP3 Assay-Product Status 49
Table 99: Cobas 8000 Analyzer Series With e 801 Module-IGF BP3 Assay-Product Description 50
Table 100: Cobas 8000 Analyzer Series With e 801 Module-IGF-1 Assay-Product Status 50
Table 101: Cobas 8000 Analyzer Series With e 801 Module-IGF-1 Assay-Product Description 50
Table 102: Sendera Discovery Pipeline Products & Ongoing Clinical Trials Overview 51
Table 103: In-Vitro Diagnostic Kit-Androgen Replacement Therapy-Product Status 51
Table 104: In-Vitro Diagnostic Kit-Androgen Replacement Therapy-Product Description 51
Table 105: Siemens Healthcare GmbH Pipeline Products & Ongoing Clinical Trials Overview 52
Table 106: ADVIA Centaur CP Immunoassay System-Vitamin D Assay-Product Status 52
Table 107: ADVIA Centaur CP Immunoassay System-Vitamin D Assay-Product Description 53
Table 108: Dimension EXL 200 Integrated Chemistry System-LOCI IPTH-Product Status 53
Table 109: Dimension EXL 200 Integrated Chemistry System-LOCI IPTH-Product Description 53
Table 110: Dimension EXL 200 Integrated Chemistry System-Vitamin D Assay-Product Status 54
Single User License:
Report can be used by individual purchaser only
Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office
Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company
INQUIRE FOR COVID-19 IMPACT ANALYSIS
Products
Alere Inc, Vitamin D Assay; AMS Diagnostics LLC, LIASYS 330 - Vitamin D Assay; AMS Diagnostics LLC, Liasys 450 - Vitamin D Assay; Beckman Coulter Inc, UniCel DxI 860i Synchron Access Clinical System - Vitamin D Assay; Carolina Liquid Chemistries Corp, CLC 480 Analyzer - Vitamin D Assay; Carolina Liquid Chemistries Corp, CLC 720i Analyzer - Vitamin D Assay; Ceres Nanosciences Inc, Nanotrap Human Growth Hormone Test; Columbia University, Diagnostic Test - Menopause; DiaSorin SpA, LIAISON - High Sclerostin Assay; DiaSorin SpA, LIAISON - Hyperphosphate Low Bone Turnover Assay; DiaSorin SpA, LIAISON XL - Sclerostin Assay; DIAsource ImmunoAssays SA, 25-OH Vitamin D Total ELISA Test; Fujirebio Diagnostics Inc, Lumipulse G1200 - Whole PTH; Immunodiagnostic Systems Holdings plc, IDS-iSYS Cortisol Assay; Immunodiagnostic Systems Holdings plc, IDS-iSYS Intact PINP Assay; Immunodiagnostic Systems Holdings plc, IDS-iSYS MGP Assay; Mindray Medical International Ltd, CL-1000i - Calcitonin Test; Mindray Medical International Ltd, CL-1000i - Intact PTH Test; Mindray Medical International Ltd, CL-1000i - Vitamin D Total Test; Mindray Medical International Ltd, CL-2000i - ACTH Test; Mindray Medical International Ltd, CL-2000i - Calcitonin Test; Mindray Medical International Ltd, CL-2000i - Cortisol Test; Mindray Medical International Ltd, CL-2000i - PTH Test; Mindray Medical International Ltd, CL-2000i - Vitamin D Total Test; Novartis AG, Rapid Diagnostic Test - Vitamin D; OJ-Bio Ltd, Parathyroid Hormone Assay; Roche Diagnostics International Ltd, Cobas 4000 Analyzer Series With e 411 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With c 501 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With c 501 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With e 601 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 6000 Analyzer Series With e 601 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 502 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 502 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 701 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 701 Module - IGF-1; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With c 702 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 602 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 602 Module - IGF-1 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 801 Module - IGF BP3 Assay; Roche Diagnostics International Ltd, Cobas 8000 Analyzer Series With e 801 Module - IGF-1 Assay; Sendera Discovery, In-Vitro Diagnostic Kit - Androgen Replacement Therapy; Siemens Healthcare GmbH, ADVIA Centaur CP Immunoassay System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL 200 Integrated Chemistry System - LOCI IPTH; Siemens Healthcare GmbH, Dimension EXL 200 Integrated Chemistry System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI Cortisol Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI IPTH Assay; Siemens Healthcare GmbH, Dimension EXL with LM Integrated Chemistry System - LOCI Vitamin D Assay; Siemens Healthcare GmbH, Dimension EXL With LM Integrated Chemistry System - Vitamin D Assay; Siemens Healthcare GmbH, Dimension Vista 1000T Intelligent Lab System - Cortisol Assay; Siemens Healthcare GmbH, Dimension Vista 1500 Intelligent Lab System - Loci Vitamin D Assay; Siemens Healthcare GmbH, Dimension Vista 3000T Intelligent Lab System - Cortisol Assay; Siemens Healthcare GmbH, Dimension Vista 500 Intelligent Lab System - Cortisol Assay; Thermo Fisher Scientific Inc, Cascadion SM Clinical Analyzer - 25OH Vitamin D Assay; Tosoh Bioscience Inc, AIA-360 - Vitamin D Test
Companies
Alere Inc
AMS Diagnostics LLC
Beckman Coulter Inc
Carolina Liquid Chemistries Corp
Ceres Nanosciences Inc
Columbia University
DiaSorin SpA
DIAsource ImmunoAssays SA
Fujirebio Diagnostics Inc
Immunodiagnostic Systems Holdings plc
Mindray Medical International Ltd
Novartis AG
OJ-Bio Ltd
Roche Diagnostics International Ltd
Sendera Discovery
Siemens Healthcare GmbH
Thermo Fisher Scientific Inc
Tosoh Bioscience Inc